Background and purpose: Patient and public involvement in clinical practice guideline development is recommended to increase guideline trustworthiness and relevance. The aim was to engage multiple sclerosis (MS) patients and caregivers in the definition of the key questions to be answered in the European Academy of Neurology guideline on palliative care of people with severe MS. Methods: A mixed methods approach was used: an international online survey launched by the national MS societies of eight countries, after pilot testing/debriefing on 20 MS patients and 18 caregivers, focus group meetings of Italian and German MS patients and caregivers. Results: Of 1199 participants, 951 (79%) completed the whole online survey and 934 from seven countries were analysed: 751 (80%) were MS patients (74% women, mean age 46.1) and 183 (20%) were caregivers (36% spouses/ partners, 72% women, mean age 47.4). Participants agreed/strongly agreed on inclusion of the nine pre-specified topics (from 89% for 'advance care planning' to 98% for 'multidisciplinary rehabilitation'), and <5% replied 'I prefer not to answer' to any topic. There were 569 free comments: 182 (32%) on the pre-specified topics, 227 (40%) on additional topics (16 guideline-pertinent) and 160 (28%) on outcomes. Five focus group meetings (three of MS patients, two of caregivers, and overall 35 participants) corroborated the survey findings. In addition, they allowed an explanation of the guideline production process and the exploration of patient-important outcomes and of taxing issues. Conclusions: Multiple sclerosis patient and caregiver involvement was resource and time intensive, but rewarding. It was the key for the formulation of the 10 guideline questions and for the identification of patient-important outcomes.
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Introduction
The incorporation of patient values into individual clinical decisions, a fundamental of shared decision making, also applies to clinical practice guideline development [1] . The ultimate aim is to address the issues that are important to health consumers (patients, caregivers and the public), sensitive to their values and preferences. Consequently, professional societies and other guideline producers have recognized the need to involve consumers in all phases of guideline development [2] . An initial and fundamental guideline phase is the formulation of the clinical questions, specifying the population, intervention, comparator and outcomes (PICO) [3] . For complex healthcare interventions, formulating PICO questions is more challenging than for questions of drug interventions, and no guidance currently exists [4, 5] . The engagement of healthcare consumers is even more important to facilitate the operational definition of these questions.
The European Academy of Neurology (EAN) has recently appointed a guideline production group ('task force' in the EAN guideline terminology) [6] to devise a clinical practice guideline on palliative care of people with severe multiple sclerosis (MS). The task force consists of health professionals from three disciplines (neurology, palliative care and rehabilitation), methodologists and patient advocates. Task force members are from nine European countries: Bulgaria, Germany, Denmark, Israel, Italy, the Netherlands, Serbia, Spain and the UK.
The guideline PICO questions were formulated obtaining information on patient values from literature search, from expert survey and from the direct engagement of MS patients and caregivers using a mixed methods (quantitative and qualitative) approach. Here, the results of this process and the main challenges encountered are described.
Materials and methods
The construction of the international online survey, its implementation, the focus group meetings (FGMs), the ethics statement, and analyses are reported in Appendix S1. For the FGMs, the consolidated criteria for reporting qualitative studies (COREQ) checklist is reported in Table S1 and guides are reported in Table S2 .
Results

Expert survey
The expert survey took place in April 2017 ( Fig. 1) : task force members invited health professionals to complete a questionnaire that contained an introduction, two open sections (on interventions and clinical outcome measures to be included in the guideline) and a section with respondent profession and expertise. Forty-seven health professionals from eight countries (Denmark, Germany, Italy, Israel, the Netherlands, Serbia, Spain and the UK) participated. Most professionals (27) were physicians (neurologists, physiatrists, palliative care physicians); eight were nurses, six therapists (physiotherapists, psychologists, occupational therapists), three social workers, one research coordinator, one hospice coordinator, one chaplain.
Based on a review of the literature [7] [8] [9] [10] [11] and on expert survey findings, the task force agreed on a set of 14 items ('questions'), which are reported in Table S3 (right column).
Piloting of the international online survey
The first version of the survey was discussed in dedicated meetings of the Danish MS society (MSS) and the Israel MSS, and was piloted/debriefed on 20 MS patients and 18 caregivers from six European countries (Bulgaria, Germany, Italy, the Netherlands, Serbia and the UK). In the Israel MSS meeting it was agreed that a survey on MS palliative care in Israel was too premature, as the discussion of palliative care and death and dying was felt to be particularly difficult within the Israeli culture at this time. The interrogative item format (Table S3 ) and the section on outcomes related to each item (not shown) were found to be difficult to understand and rate; the explanation paragraph of each item was considered complex; five of the 14 items were judged too taxing. As a result, the following changes were made to the first version: an affirmative item format was used; the list of outcomes attached to each question was removed; the explanation paragraph of each item was simplified; five items were removed (Table S3) .
Survey implementation and findings
Between July and December 2017, the online survey was carried out in all the task force countries except Israel (see above). Participation was overall good, except for the UK ( Table 1) .
The analysis was performed on 934 participants from seven countries who provided information on their status (MS patient or caregiver) (Tables 2 and  3 ). MS patients (751, 80%) outnumbered caregivers (183, 20%). Mean patient age was 46.1 years (range 19-82); 558 (74%) were women, and 428 (57%) had tertiary education (college or university degree). Notably, 49% of the patients were fully ambulatory, and 23% had been diagnosed within the last 5 years, with consistent figures across all the countries except the Netherlands where the MS patients were more disabled, indicating that MS patients were interested in the topic of palliative care regardless of their clinical status. Patient employment status varied, with highest unemployment in Spain and Bulgaria (14%) and lowest values in the Netherlands and Denmark (0%-3%). Most of the caregivers were women (72%), their mean age was 47.4 years (range 18-77) and 64% had tertiary education. One-third of the caregivers were the patient's spouse or partner. The MS patients they cared for were of similar age (P = 0.39) and disease duration (v 2 = 3.2; P = 0.20) albeit more disabled (v 2 = 48.4; P < 0.001) compared to the patients who completed the survey. The median (interquartile range) survey completion time was 8 (5-10) min in patients and 8 (6-11) min in caregivers (P = 0.07). Participants replying 'I prefer not to answer' were consistently few amongst MS patients and caregivers; highest values were found for 'advance care planning' (4% of MS patients and 5% of caregivers) and 'specialist palliative care' (3% of MS patients and 4% of caregivers). Participants agreed or strongly agreed on inclusion of the nine pre-specified topics, with the lowest value for 'advance care planning' (89% of both patients and caregivers) and the highest value for 'multidisciplinary rehabilitation' (99% of MS patients, 97% of caregivers). These figures were close to those of the 231 participants excluded from the analysis as they did not provide information on their status (data not shown). There were 569 free comments, categorized into four domains: guideline pre-specified topics (182 comments, 32%); additional topics, pertinent to the guideline (16 comments, 3%); additional topics, not pertinent to the guideline (211, 37%), and outcomes (160, 28%). Table 4 reports the distribution of comments across the four domains by country; details on domain contents are reported in the footnotes.
One-third of the comments on pre-specified guideline topics were on symptom management and rehabilitation; it was not possible from the comments to separate rehabilitation from multidisciplinary rehabilitation; thus topics 1 and 2 were merged, followed by palliative care and specialist palliative care (23%), and by emotional and practical support for caregivers (16%).
The two guideline-pertinent additional topics were 'voluntary euthanasia' (related to question 14; Table S3 ), proposed by 12 patients from Denmark, Germany, the Netherlands and Italy and three caregivers from Denmark and Germany; and 'sheltered housing/assisted living', proposed by one German patient.
Additional topics not pertinent to the guideline population but to MS patients at large regarded four main domains: 'welfare' (104/211 comments, 49%), 'empowerment' (54 comments, 25%), 'disease management' (mainly related to the MS diagnosis; 31 comments, 15%) and 'lifestyle' (23 comments, 11%).
Fourteen overarching outcomes were mentioned, which included patient outcomes (from patient participation and quality of life to quality of death and dying), caregiver outcomes, care-related outcomes and costs (Table 4) .
Of 934 participants, 120 (13%) commented on the survey or on the guideline project. Of these, most participants (110, 92%) expressed appreciation of the initiative. Ten participants (8%) reported some criticisms: three patients considered the survey as not exhaustive, useless, or futile; one patient commented that topics 8 and 9 were the same; six participants criticized the patient general section of the survey.
FGM findings
Patient FGMs lasted 96, 105 and 110 min; two had seven participants and one had 11 participants (total n = 25). The median age of the patients was 54 years (range 53-75); 19 (76%) were women, and the median Expanded Disability Status Scale was 8.0 (range 6.0-9.5). Caregiver FGMs lasted 120 and 79 min, both with five participants (total n = 10); their median age was 56 years (range 44-86); six (60%) were women; they were the spouse (n = 5), widow (n = 2) or Values are given as number (%). The UK was excluded from the analysis as participation was sub-threshold [13] . 11%) , emotional well-being (14, 9%), advance directive/living will (14, 9%), service coordination (10, 6%), caregiver emotional well-being (10, 6%), quality of life (8, 5%), quality of death/dying (8, 5%), satisfaction with care/services (8, 5%), patient-clinician relationship (5, 3%), caregiver burden (4, 2%), complicated bereavement (3, 2%), costs (2, 1%). Values are given as number (%). The UK was excluded from the analysis as participation was sub-threshold [13] .
© 2018 EAN widower (n = 1) of MS patients who died in the previous year, mother (n = 1) and daughter (n = 1). After a short introduction and ice-breaking, 30-40 min was dedicated to the description of the guideline, the main phases of its production, and the reasons for involving patients and caregivers from the formulation of the clinical questions. All participants considered the guideline a valuable and necessary instrument for all the professionals caring for people with severe MS: physicians (includng family and emergency care physicians), therapists, nurses, social workers, and formal and informal caregivers. The FGM themes, components and illustrative citations are reported in Table 5 . Participants who had not been in touch with palliative care benefited from the explanation and discussion, as most of them thought the discipline pertained exclusively to end-oflife care and cancer (citations 1-3). This was different for participants who had experienced palliative care (citations 4, 5). End-of-life issues did crop up as a key guideline topic (citations 6-10). Another theme was that of requirements for severely affected MS patients: peer socialization (citations 11, 12) and case management, expressed by both relatives and patients (citations 13, 14) , who often felt overwhelmed and unsupported, for instance after discharge from hospital and rehabilitation. Outcomes encompassed symptom control (citations 1, 3, 4) , quality of life (citation 3), role preservation (of both patient and caregiver -citations 15, 16), participation (citation 17), competence of professionals and caregivers (citations 18, 19), quality of care (citation 5), living will (citation 7), and caregiver burden (citation 10). In Germany patients' emotional well-being and quality of life were considered the most important guideline outcomes, whilst unplanned hospitalization and costs were seen as the least important.
CLIENT INVOLVEMENT IN GUIDELINE FORMULATION
The main outcomes and challenges of the patient and caregiver consultation are summarized in Table 6 . Based on these findings, the task force formulated the guideline questions and detailed each PICO component (Table S4) . Four of the original questions (Table S3) were deemed of lesser importance and subsidiary to specific guideline questions: original question 6 'early palliative care' to PICO question 4; original question 8 'goal setting' to PICO questions 2, 4, 5; original question 11 'anticipation of crises' to PICO question 5; and original question 12 'best place of palliative care' to PICO questions 4, 5.
Discussion
Offering the best care possible to the highest number of patients and reducing variations in service delivery are the key issues for most healthcare systems and the main reason for producing clinical practice guidelines [14] . Involvement of health service users in clinical guideline production has long been advocated but insufficiently undertaken, and the best ways to engage users remain unclear [15] [16] [17] . Here, the experience of an international patient and caregiver involvement is reported, which was time and resource intensive and employed a mixed method. A crucial role in this process was played by the National Multiple Sclerosis Society of each participating country, and particularly by a task force member who was an MS patient and also a member of the MS International Federation, and of the Danish national MS society. She was key in bridging the issues of the MS patients to those of the health professionals and researchers. The online survey allowed participation of a geographically varied population and by being anonymous facilitated openness and trustworthiness. However, it required proficiency with online technology, and the contents of the first survey were streamlined to improve clarity and acceptability. Findings indicated that the survey was well accepted (skipped topics were <5%, negative comments were rare) and information rich: MS patients and caregivers consistently agreed on the inclusion of the nine proposed topics and provided additional proposals and comments (Table 6 ). The FGMs allowed the explanation of the process of guideline production, the identification of patientimportant outcomes, and deliberation about taxing issues ( Table 6 ). The consultation process as a whole was time and resource intensive (Fig. 1) . It was rewarding for the formulation of key questions that • Selection of online-proficient and well-educated participants (57% of the patients and 64% of the caregivers had college or university degree)
• Time and resource consuming (survey setup, translation into the target languages, piloting, revision, conduction and analysis; Figure 1) • Performed in only two of the nine guideline task force countries
• The combination of previous and current caregivers in the same meeting was challenging
• Not all the pre-specified guideline topics could be discussed
• Not a pre-planned action (no dedicated resources)
MS, multiple sclerosis.
were substantiated by patients and caregivers and also for the recognition of subsidiary topics within the guideline scope.
Limitations
The online survey contents were not linguistically validated and participation differed markedly between countries. The FGMs could be organized only in two countries; not all the pre-specified guideline topics could be discussed in the FGMs; the combination of previous and current caregivers in the same FGM was challenging ( Table 6 ). The need for more time devoted to the task emerged; however, the organization of more training for partnering was out of the reach of the task force.
Conclusions
Multiple sclerosis patients and caregivers validated the nine questions devised by our task force (with health professional input), identified additional issues related to question 14 (voluntary euthanasia, assisted suicide), sheltered housing/assisted living, case management and client-important overarching outcomes. This led to the formulation of 10 PICO questions for this guideline. Our pre-planned approach to engage patients and caregivers from the very beginning of guideline development is in line with current recommendations [3, 17] . This was demanding but attainable, also at an international level. Our findings add to the growing body of literature showing that engaging patients in guideline development is feasible and impacts the process (here, the selection and formulation of the guideline questions) [15, 16, 18, 19] . Table S1 . Consolidated criteria for reporting qualitative studies (COREQ) checklist. Items 30-32 were not completed as they do not imply the provision of information but a judgement on the analysis. N.R., not reported; N.A., not applicable. Table S2 . Focus group meeting guides. Table S3 . The nine items ('topics') of the online survey (left column) are listed in the survey order. The 14 items ('questions') of the first version are reported in the right column for comparison. Items 10-14 correspond to the removed items. Table S4 . The 10 clinical questions formulated by the task force after completion of the consultation, each detailed in terms of population, intervention, comparator, outcomes and setting. Outcomes reported in bold are those identified by patients and caregivers.
